SCHEMBL6467263

SCHEMBL6467263

COc1cccc(CN(Cc2cccc(OC(F)(F)F)c2)C(=O)c2cccc(C(N)=O)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.56
PARP1 P09874 1/20 0.51
GRIN2B Q13224 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
SLC2A1 P11166 5/20 0.48
SLC2A4 P14672 2/20 0.48
LPAR1 Q92633 2/20 0.48
LPAR5 Q9H1C0 2/20 0.48
HSD17B2 P37059 2/20 0.47
RIPK1 Q13546 1/20 0.45
SLC2A8 Q9NY64 1/20 0.44
CETP P11597 1/20 0.44
MMP13 P45452 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6461963 0.84 SLC2A1 (0.57) PARP1SMN1; SMN2SLC2A1SLC2A4LPAR1
SCHEMBL11900347 0.80 KMT2A (0.67) PARP1SLC2A1SLC2A4LPAR1LPAR5
SCHEMBL711132 0.75 PARP1 (0.61) TRPM8PARP1RIPK1
SCHEMBL29448761 0.75 PARP1 (0.61) TRPM8PARP1RIPK1
SCHEMBL24343532 0.75 SLC2A1 (0.63) SMN1; SMN2SLC2A1SLC2A4LPAR1LPAR5
SCHEMBL7179678 0.74 HSD17B2 (0.56) PARP1SLC2A1SLC2A4HSD17B2MEN1
SCHEMBL30246316 0.74 HSD17B2 (0.56) PARP1SLC2A1SLC2A4HSD17B2MEN1
SCHEMBL4639564 0.74 MRGPRX4 (0.61) TRPM8RIPK1
Hydrochloric Acid SCHEMBL1268771 0.74 PARP1 (0.59) TRPM8PARP1RIPK1
SCHEMBL5334251 0.74 MMP13 (0.81) MMP13HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed